BridgeMD
New treatment option for Food Allergy
Official title Analysis of the Prevalence of Sensitization to Plants Containing Gibberellins Using Realistic Skin Prick Tests
ClinicalTrials.gov ID: NCT06183398
What this study is testing
- What it's testing
- Gibberellin-related proteins (GRPs) are proteins contained in both pollens and vegetables and are associated with an increased risk of severe food allergy reactions. The best characterized one the only one for which a specific IgE (Immunoglobulin E) may be dosed in current clinical practice is Pru p 7, an allergen contained in peaches (Prunus persica).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 5 and older
You may be able to join if
- Patients aged at least 5 years
- Patients consulting at the Allergy Unit of the University Hospital of Montpellier for any type of allergy work-up/evaluation
- Oral consent from the patient and, where applicable, from at least one of the patient's legal representatives in the case of minors.
You likely can't join if
- Patients treated with antihistamines or psychotropic drugs with antihistaminic action during the 7 days prior to inclusion
- Patients with pathologies that prevent the performance of prick tests (e.g. severe peripheral neuropathy, cutaneous anergy).
- Patients with dermographism.
- Patient taking part in another study which may influence the results of the prick tests.
- Patients in an exclusion period determined by a previous study.
- Pregnant, parturient or breast-feeding women.
See the full eligibility criteria
- Patients aged at least 5 years
- Patients consulting at the Allergy Unit of the University Hospital of Montpellier for any type of allergy work-up/evaluation
- Oral consent from the patient and, where applicable, from at least one of the patient's legal representatives in the case of minors.
- Patients treated with antihistamines or psychotropic drugs with antihistaminic action during the 7 days prior to inclusion
- Patients with pathologies that prevent the performance of prick tests (e.g. severe peripheral neuropathy, cutaneous anergy).
- Patients with dermographism.
- Patient taking part in another study which may influence the results of the prick tests.
- Patients in an exclusion period determined by a previous study.
- Pregnant, parturient or breast-feeding women.
- Patients or their legal representatives under court protection, guardianship or trusteeship.
- Patients or their legal representatives who are not members or beneficiaries of a health insurance scheme.
- Patient or his/her legal representative unable to read and understand French fluently.
The study team makes the final eligibility decision.
Where it's taking place
- Montpellier, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 5 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montpellier, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.